ONTARIO CANCER INSTITUTE

Organization

TORONTO, CA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Verotoxin pharmaceutical compositions and medical treatments therewith
- Patent number 7,560,426
- Issue date Jul 14, 2009
- HSC Research and Development Limited Partnership
- Clifford A. Lingwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Verotoxin pharmaceutical compositions and medical treatments therewith
- Patent number 7,208,468
- Issue date Apr 24, 2007
- HSC Research and Development Limited Partnership
- Clifford A. Lingwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Verotoxin pharmaceutical compositions and medical treatments therewith
- Patent number 6,835,710
- Issue date Dec 28, 2004
- HSC Research and Development Limited Partnership
- Clifford A. Lingwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD45 disrupted nucleic acid
- Patent number 6,664,107
- Issue date Dec 16, 2003
- Ontario Cancer Institute, University Health Network
- Tak Wah Mak
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of identifying inhibitors of sensor histidine kinases throu...
- Patent number 6,162,627
- Issue date Dec 19, 2000
- University of Medicine & Dentistry of New Jersey
- Masayori Inouye
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of identifying inhibitors of sensor histidine kinases throu...
- Patent number 6,077,682
- Issue date Jun 20, 2000
- University of Medicine and Dentistry of New Jersey
- Masayori Inouye
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for selectively purging CD77+ cells from bone marrow
- Patent number 5,801,145
- Issue date Sep 1, 1998
- Ontario Cancer Institute
- Jean Gariepy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant mouse lacking the expression of interferon regulatory factor...
- Patent number 5,731,490
- Issue date Mar 24, 1998
- The Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mouse having a disrupted CD4 gene
- Patent number 5,698,765
- Issue date Dec 16, 1997
- The Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant mouse having a disrupted TNFRp55
- Patent number 5,684,222
- Issue date Nov 4, 1997
- Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Branched synthetic peptide conjugate
- Patent number 5,674,977
- Issue date Oct 7, 1997
- The Ontario Cancer Institute
- Jean Gariepy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)
- Patent number 5,675,059
- Issue date Oct 7, 1997
- The Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mouse having a disrupted lck gene
- Patent number 5,625,122
- Issue date Apr 29, 1997
- The Ontario Cancer Institute
- Tak W. Mak
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Knockout mice
- Patent number 5,616,491
- Issue date Apr 1, 1997
- Ontario Cancer Institute
- Tak W. Mak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Knockout mice
- Patent number 5,557,032
- Issue date Sep 17, 1996
- Ontario Cancer Institute
- Tak W. Mak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-2 receptor deficient mammals
- Patent number 5,532,158
- Issue date Jul 2, 1996
- Ontario Cancer Institute
- Haruhiko Suzuki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant mouse lacking CD8 surface marker
- Patent number 5,530,178
- Issue date Jun 25, 1996
- The Ontario Cancer Institute
- Tak W. Mak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoassay method for determining the specificity of binding of a...
- Patent number 5,223,400
- Issue date Jun 29, 1993
- The Ontario Cancer Institute
- Victor Ling
- G01 - MEASURING TESTING
Information Patent Grant
Intestinal oncofetal gene
- Patent number 5,171,850
- Issue date Dec 15, 1992
- The Ontario Cancer Institute
- Jorge E. Filmus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell specific cDNA clone
- Patent number 4,923,799
- Issue date May 8, 1990
- The Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for selecting hybridomas producing antibodies specific to th...
- Patent number 4,837,306
- Issue date Jun 6, 1989
- The Ontario Cancer Institute
- Victor Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiotherapy apparatus
- Patent number 4,733,653
- Issue date Mar 29, 1988
- The Ontario Cancer Institute
- Philip K. M. Leung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell specific CDNA clone
- Patent number 4,713,332
- Issue date Dec 15, 1987
- The Ontario Cancer Institute
- Tak W. Mak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anthropomorphic phantoms
- Patent number 4,638,502
- Issue date Jan 20, 1987
- The Ontario Cancer Institute
- Martin J. Yaffe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ultrasonic imaging device
- Patent number 4,495,817
- Issue date Jan 29, 1985
- The Ontario Cancer Institute
- John W. Hunt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing self-reproducing mammalian pancreatic islet-li...
- Patent number 4,439,521
- Issue date Mar 27, 1984
- Ontario Cancer Institute
- Michael C. Archer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cylindrical transducer ultrasonic scanner
- Patent number 4,339,952
- Issue date Jul 20, 1982
- Ontario Cancer Institute
- Francis S. Foster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conical transducer ultrasonic scanning
- Patent number 4,325,258
- Issue date Apr 20, 1982
- Ontario Cancer Institute
- Francis S. Foster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 30

Research Projects

Information Research Project
A unique murine model for human aging
- Application id 6818368
- Award notice date Sep 23, 2004
Information Research Project
Enhancement of Gene Therapy Outcomes for Fabry Disease
- Application id 6797751
- Award notice date Sep 3, 2004
Information Research Project
Enhancement of Gene Therapy Outcomes for Fabry Disease
- Application id 6660318
- Award notice date Sep 1, 2003
Information Research Project
OCULAR MELANOMA
- Application id 6649655
- Award notice date Aug 13, 2003
Information Research Project
GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1
- Application id 6629814
- Award notice date Jun 10, 2003
Information Research Project
Effects of diet on growth hormone-IGF-1 axis
- Application id 6522660
- Award notice date Sep 20, 2002
Information Research Project
Enhancement of Gene Therapy Outcomes for Fabry Disease
- Application id 6528362
- Award notice date Sep 16, 2002
Information Research Project
OCULAR MELANOMA
- Application id 6525017
- Award notice date Aug 16, 2002
Information Research Project
MAMMOGRAPHIC DENSITITES IN CHINESE AND CAUCASIAN WOMEN
- Application id 6514524
- Award notice date Jul 11, 2002
Information Research Project
GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1
- Application id 6509622
- Award notice date May 27, 2002
Information Research Project
Enhancement of Gene Therapy Outcomes for Fabry Disease
- Application id 6501309
- Award notice date Sep 29, 2001
Information Research Project
Effects of diet on growth hormone-IGF-1 axis
- Application id 6320498
- Award notice date Sep 19, 2001
Information Research Project
MAMMOGRAPHIC DENSITIES AND RISK OF BREAST CANCER
- Application id 6377429
- Award notice date Sep 7, 2001
Information Research Project
OCULAR MELANOMA
- Application id 6384546
- Award notice date Jul 30, 2001
Information Research Project
GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1
- Application id 6372306
- Award notice date Jun 7, 2001
Information Research Project
MAMMOGRAPHIC DENSITITES IN CHINESE AND CAUCASIAN WOMEN
- Application id 6287877
- Award notice date May 11, 2001
Information Research Project
GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1
- Application id 6168888
- Award notice date Sep 14, 2000
Information Research Project
MAMMOGRAPHIC DENSITIES AND RISK OF BREAST CANCER
- Application id 6174116
- Award notice date Sep 12, 2000
Information Research Project
OCULAR MELANOMA
- Application id 6315508
- Award notice date Jul 31, 2000
Information Research Project
HMG COA REDUCTASE INHIBITION IN THE TREATMENT OF AML
- Application id 2896734
- Award notice date Aug 19, 1999
Information Research Project
OCULAR MELANOMA
- Application id 2888263
- Award notice date Jul 26, 1999
Information Research Project
GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1
- Application id 2823928
- Award notice date May 24, 1999
Information Research Project
HMG COA REDUCTASE INHIBITION IN THE TREATMENT OF AML
- Application id 2718890
- Award notice date Jul 31, 1998
Information Research Project
OCULAR MELANOMA
- Application id 2710959
- Award notice date Jul 24, 1998
Information Research Project
OCULAR MELANOMA
- Application id 2459097
- Award notice date Jul 28, 1997
Information Research Project
OCULAR MELANOMA
- Application id 2161043
- Award notice date Jul 25, 1996
Information Research Project
OCULAR MELANOMA
- Application id 2161042
- Award notice date Jul 26, 1995
Information Research Project
OCULAR MELANOMA
- Application id 2161041
- Award notice date Aug 1, 1994
Information Research Project
COMS--COOPERATING CLINIC
- Application id 3559495
- Award notice date Jul 15, 1993
Information Research Project
COMS--COOPERATING CLINIC
- Application id 3559494
- Award notice date Jul 27, 1992

ONTARIO CANCER INSTITUTE

Organization

Patents Grantslast 30 patents

Verotoxin pharmaceutical compositions and medical treatments therewith

Verotoxin pharmaceutical compositions and medical treatments therewith

Verotoxin pharmaceutical compositions and medical treatments therewith

CD45 disrupted nucleic acid

Methods of identifying inhibitors of sensor histidine kinases throu...

Methods of identifying inhibitors of sensor histidine kinases throu...

Method for selectively purging CD77+ cells from bone marrow

Mutant mouse lacking the expression of interferon regulatory factor...

Mouse having a disrupted CD4 gene

Mutant mouse having a disrupted TNFRp55

Branched synthetic peptide conjugate

Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)

Mouse having a disrupted lck gene

Knockout mice

Knockout mice

Interleukin-2 receptor deficient mammals

Mutant mouse lacking CD8 surface marker

Immunoassay method for determining the specificity of binding of a...

Intestinal oncofetal gene

T cell specific cDNA clone

Method for selecting hybridomas producing antibodies specific to th...

Radiotherapy apparatus

T cell specific CDNA clone

Anthropomorphic phantoms

Ultrasonic imaging device

Method for producing self-reproducing mammalian pancreatic islet-li...

Cylindrical transducer ultrasonic scanner

Conical transducer ultrasonic scanning

NIH Research Projectlast 12 months

Research Projects

A unique murine model for human aging

Enhancement of Gene Therapy Outcomes for Fabry Disease

Enhancement of Gene Therapy Outcomes for Fabry Disease

OCULAR MELANOMA

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1

Effects of diet on growth hormone-IGF-1 axis

Enhancement of Gene Therapy Outcomes for Fabry Disease

OCULAR MELANOMA

MAMMOGRAPHIC DENSITITES IN CHINESE AND CAUCASIAN WOMEN

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1

Enhancement of Gene Therapy Outcomes for Fabry Disease

Effects of diet on growth hormone-IGF-1 axis

MAMMOGRAPHIC DENSITIES AND RISK OF BREAST CANCER

OCULAR MELANOMA

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1

MAMMOGRAPHIC DENSITITES IN CHINESE AND CAUCASIAN WOMEN

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1

MAMMOGRAPHIC DENSITIES AND RISK OF BREAST CANCER

OCULAR MELANOMA

HMG COA REDUCTASE INHIBITION IN THE TREATMENT OF AML

OCULAR MELANOMA

GENETIC ANALYSIS OF MAMMALIAN TELOMERASE PROTEINS TEP1

HMG COA REDUCTASE INHIBITION IN THE TREATMENT OF AML

OCULAR MELANOMA

OCULAR MELANOMA

OCULAR MELANOMA

OCULAR MELANOMA

OCULAR MELANOMA

COMS--COOPERATING CLINIC

COMS--COOPERATING CLINIC